Latvia - Export of Insulin Not in Dosage Forms
In 2017, the country was ranked number 39 among other countries in Export of Insulin Not in Dosage Forms with $260.46. Latvia is overtaken by Namibia, which was ranked number 38 with $402.37 and is followed by Bangladesh with $214. United States lead the ranking with $80,915,499.85 in 2019, -13.6% versus 2018. Netherlands, Denmark and Czech Republic respectively ranked number 2, 3 and 4 in this ranking. Singapore recorded the best 5 years average growth at +89.4% per year, while Uganda recorded the worst performance at -74.1% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2017 | 260.46 |
| 2016 | 780.09 |
| 2015 | 132,919.36 |
| 2014 | 1,349,918.00 |
| 2013 |
Download all data from 2001 to 2017
How does Latvia rank in Export of Insulin Not in Dosage Forms?
| # | 43 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
80,915,499.85 | 2019 | -13.6 % | -6.0 % | View data | |
| 2 |
#2
Netherlands
|
2,226,098.50 | 2018 | -12.0 % | NA | View data | |
| 38 |
#38
Namibia
|
402.37 | 2017 | NA | NA | View data | |
| 39 |
#39
Latvia
|
260.46 | 2017 | -66.6 % | NA | View data | |
| 40 |
#40
Bangladesh
|
214.00 | 2015 | NA | NA | View data | |